Evidence map›Paper›PMID 31465472›Full record

ArticlePloS one2019

Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21.

Carlo Lisci, Jo E Lewis, Zoe C T R Daniel, Tyler J Stevenson, Chloe Monnier, Hayley J Marshall, Maxine Fowler, Francis J P Ebling, Gian-Luca Ferri, Cristina Cocco and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. The molecular identity of the TLQP-21 peptide receptor.Cellular and molecular life sciences : CMLS · 2021
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Carlo LisciNEF-Laboratory, Dept. of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Jo E LewisSchool of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
Zoe C T R DanielSchool of Biosciences, University of Nottingham Sutton Bonington Campus, Nottingham, United Kingdom.
Tyler J StevensonInstitute for Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0003-2644-9685
Chloe MonnierSchool of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
Hayley J MarshallSchool of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
Maxine FowlerSchool of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
Francis J P EblingSchool of Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom.
Gian-Luca FerriNEF-Laboratory, Dept. of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Cristina CoccoNEF-Laboratory, Dept. of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Preeti H JethwaSchool of Biosciences, University of Nottingham Sutton Bonington Campus, Nottingham, United Kingdom.ORCID 0000-0003-4401-284X
University of Nottingham · GBUniversity of Cagliari · ITUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TLQP-21, a peptide encoded by the highly conserved vgf gene, is expressed in neuroendocrine cells and has been the most prominent VGF-derived peptide studied in relation to control of energy balance. The recent discovery that TLQP-21 is the natural agonist for the complement 3a receptor 1 (C3aR1) has revived interest in this peptide as a potential drug target for obesity. We have investigated its function in Siberian hamsters (Phodopus sungorus), a rodent that displays natural seasonal changes in body weight and adiposity as an adaptation to survive winter. We have previously shown that intracerebroventricular administration of TLQP-21 reduced food intake and body weight in hamsters in their long-day fat state. The aim of our current study was to determine the systemic actions of TLQP-21 on food intake, energy expenditure and body weight, and to establish whether adiposity affected these responses. Peripheral infusion of TLQP-21 (1mg/kg/day for 7 days) in lean hamsters exposed to short photoperiods (SP) reduced cumulative food intake in the home cage (p<0.05), and intake when measured in metabolic cages (P<0.01). Energy expenditure was significantly increased (p<0.001) by TLQP-21 infusion, this was associated with a significant increase in uncoupling protein 1 mRNA in brown adipose tissue (BAT) (p<0.05), and body weight was significantly reduced (p<0.05). These effects of systemic TLQP-21 treatment were not observed in hamsters exposed to long photoperiod (LP) with a fat phenotype. C3aR1 mRNA and protein were abundantly expressed in the hypothalamus, brown and white adipose tissue in hamsters, but changes in expression cannot explain the differential response to TLQP-21 in lean and fat hamsters.

Indexed as

PhotoperiodAdiposityAnimalsBiomarkersBrainCarbon DioxideCricetinaeEnergy MetabolismFemaleGene ExpressionNeuropeptidesOxygenPeptide FragmentsReceptors, ComplementBiomarkersCarbon DioxideNeuropeptidesOxygenPeptide FragmentsReceptors, ComplementTLQP-21 peptideVGF peptide

Identifiers

PMID31465472
PMCPMC6715173
OpenAlexW2970444380

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.